Skip to main content
Clinical Trials/NCT02570061
NCT02570061
Completed
Phase 3

Recruiting to Clinical Trials on the Telephone

Gorm Greisen0 sites125 target enrollmentJuly 2013

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Parental Consent
Sponsor
Gorm Greisen
Enrollment
125
Primary Endpoint
total communication score
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study examined the use of the telephone for the purpose of informing expectant mothers about a randomized clinical trial assessing neonatal Bacille Calmette-Guérin vaccination. Expectant mothers who were contacted for participation in a vaccination trial (the Calmette study, NCT01694108) were randomized to receive information by telephone or at a face-to-face consultation. The primary outcome was a communication score, consisting of comprehension of information about the study and satisfaction with the information process. The outcome was measured using a questionnaire two weeks after the information was provided and two and a half months after birth.

Detailed Description

Informed consent is an essential element of clinical research. Obtaining consent, however, may be challenging. The use of the telephone for giving information and obtaining consent may be practical but little formal research has been done. This study examined the use of the telephone for the purpose of informing expectant mothers about a randomized clinical trial assessing neonatal Bacille Calmette-Guérin vaccination. Expectant mothers who were contacted for participation in the Calmette Study were randomised to receive information by telephone or at a face-to-face consultation. The primary outcome was a communication score, consisting of comprehension of information about the study and satisfaction with the information process. The outcome was measured using a questionnaire two days after the information was provided and two and a half months after birth.

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
February 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Gorm Greisen
Responsible Party
Sponsor Investigator
Principal Investigator

Gorm Greisen

consultant, professor

Rigshospitalet, Denmark

Eligibility Criteria

Inclusion Criteria

  • Planning to give birth at Rigshospitalet

Exclusion Criteria

  • Prior contact to the Calmette trial staff
  • Unable/unwilling to come to hospital for face-to-face information
  • Declining participation in this trial

Outcomes

Primary Outcomes

total communication score

Time Frame: 2 weeks after information was given

Sum of scores of answers to all questions in a proprietary questionnaire

Secondary Outcomes

  • satisfaction subscore(2.5 months after birth of the infant)
  • comprehension subscore(2.5 months after birth of the infant)

Similar Trials